Tiger Woods, Golf Injuries, and Stem Cell Therapy: What Patients Should Know

Tiger Woods’ history of injuries has drawn attention to how golfers manage pain and recovery. In 2010, Woods publicly described receiving platelet-rich plasma, or PRP, for knee and Achilles injuries. That treatment should not be confused with stem cell therapy.

His experience provides a starting point for a broader question: what should golfers know about stem cell treatments being studied for joint and tendon conditions?

How stem cell therapy differs from PRP

PRP uses a concentrated preparation of platelets from a patient’s blood. Stem cell approaches involve cells, with different sources, preparation methods, and intended uses. The two treatments are distinct, and evidence about one cannot establish the effectiveness of the other.

What golfers should know

Stem cell approaches are an area of ongoing research. Patients should understand the specific product being proposed, the evidence for their diagnosis, its regulatory status, and the potential risks.

The FDA states that regenerative medicine products described in its consumer guidance have not been approved to treat orthopedic conditions such as osteoarthritis, tendonitis, or knee and shoulder pain. Claims that treatment will rebuild cartilage, prevent surgery, or guarantee a return to golf should be viewed carefully.

Start with an accurate diagnosis

For golfers experiencing persistent pain, the first step is identifying the cause. A clinical evaluation can help patients understand their condition and discuss appropriate treatment options, expected outcomes, and rehabilitation.

Learn more about stem cell therapy considerations at NovaGenix in Jupiter.

Sources: Tiger Woods’ press conference and FDA patient guidance.

‍